Back to TUDOR INVESTMENT CORP ET AL TUDOR INVESTMENT CORP ET AL

RYTMRYTM
Showing 6 of 19 quarters

Position history for TUDOR INVESTMENT CORP ET ALTUDOR INVESTMENT CORP ET AL's holdings in RHYTHM PHARMACEUTICALS INC

TUDOR INVESTMENT CORP ET AL holds 13,886 shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $1.5M as of 2026-Q2. The position was decreased (-29.3% shares). RYTM represents 0.0% of TUDOR INVESTMENT CORP ET AL's portfolio.

Current Value

$1.5M

Current Shares

13,886

Total Value Change

+$688,348

Total Shares Change

-1,359

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
13,886
-29.3%
$1.5M0.0%$111.03
0
2026-Q1
New
19,646
-
$1.7M0.0%$89.56
36
2025-Q3
Exited
0
-100.0%
$00.0%$100.64
0
2025-Q2
Decreased
4,272
-85.5%
$269,9480.0%$62.73
0
2025-Q1
Increased
29,513
+93.6%
$1.6M0.0%$54.80
41
2024-Q4
New
15,245
-
$853,4150.0%$56.34
34

Other major holders of RYTM: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used